Evidence map›Paper›PMID 42168330›Full record

ArticleCommunications biology2026

Pan-cancer analysis of single-cell profiles with polygenic signals reveals genetic influences on tumor immunity across cancers.

Chunyu Deng, Ka Li, Yunlong Ma, Jingjing Li, Yu Li, Mu Su, Yijun Zhou, Yaru Zhang, Jianzhong Su, Yan Zhang

Abstract read
In one paragraph

Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chunyu Deng *Faculty of Life Sciences and Medicine, Harbin Institute of Technology, Harbin, China.
Ka Li *Faculty of Life Sciences and Medicine, Harbin Institute of Technology, Harbin, China.
Yunlong Ma *Oujiang Laboratory, Zhejiang Lab for Regenerative Medicine, Vision, and Brain Health, Wenzhou, Zhejiang, China.
Jingjing LiOujiang Laboratory, Zhejiang Lab for Regenerative Medicine, Vision, and Brain Health, Wenzhou, Zhejiang, China.ORCID 0000-0002-9882-7377
Yu LiDepartment of Pathology, Qiqihar Medical University, Qiqihar, China.
Mu SuFaculty of Life Sciences and Medicine, Harbin Institute of Technology, Harbin, China.
Yijun ZhouOujiang Laboratory, Zhejiang Lab for Regenerative Medicine, Vision, and Brain Health, Wenzhou, Zhejiang, China.
Yaru ZhangOujiang Laboratory, Zhejiang Lab for Regenerative Medicine, Vision, and Brain Health, Wenzhou, Zhejiang, China.
Jianzhong SuOujiang Laboratory, Zhejiang Lab for Regenerative Medicine, Vision, and Brain Health, Wenzhou, Zhejiang, China. sujz@wmu.edu.cn.ORCID 0000-0003-1054-6042
Yan ZhangFaculty of Life Sciences and Medicine, Harbin Institute of Technology, Harbin, China. zhangtyo@hit.edu.cn.ORCID 0000-0002-5307-2484

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inherited genetic variation can weaken the ability of the immune system to detect and eliminate malignant cells, limiting the effectiveness of cancer immunotherapy. However, how germline polymorphisms shape the tumor immune microenvironment across cancers remains unclear. Here, we present a polygenic analysis framework that integrates single-cell RNA sequencing with GWAS summary statistics across 14 cancer types to identify genes, immune cells, and functional programs linked to cancer risk. We identify three major genetic modules associated with T cells, B cells, and myeloid cells, and show that the T-cell module is strongly linked to cytotoxic and regulatory T cells, particularly in melanoma and breast cancer. We also identify trait-related genes, including CST7, that are associated with cytokine signaling and antigen presentation. In addition, we develop a deep-learning model that predicts immunotherapy response from both tissue and blood samples, supporting the potential of integrated germline and immune features as predictive biomarkers. Together, these findings provide a framework for understanding how inherited variation shapes tumor immunity and may guide biomarker development for cancer immunotherapy.

Indexed as

Multifactorial InheritanceNeoplasmsSingle-Cell AnalysisGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansTumor Microenvironment

Identifiers

PMID42168330
PMCPMC13462604

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.